Free Trial

Leap Therapeutics (LPTX) SEC Filings & 10K Form

Leap Therapeutics logo
$0.29 +0.01 (+2.08%)
As of 01:27 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Recent Leap Therapeutics SEC Filings

DateFilerForm TypeView
07/01/2025
3:30 PM
Leap Therapeutics (Issuer)
O'Mahony John Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2025
3:30 PM
LAWLOR AUGUSTINE (Reporting)
Leap Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2025
3:31 PM
Baum Jason (Reporting)
Leap Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2025
6:15 AM
Leap Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/13/2025
6:10 AM
Leap Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/13/2025
5:51 AM
Leap Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/25/2025
7:52 PM
Leap Therapeutics (Filer)
Form DEF 14A
04/25/2025
7:54 PM
Leap Therapeutics (Filer)
Form DEFA14A
04/25/2025
7:55 PM
Leap Therapeutics (Filer)
Form ARS
04/01/2025
8:51 PM
Leap Therapeutics (Issuer)
Sirard Cynthia (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2025
8:51 PM
Leap Therapeutics (Issuer)
Mirabelli Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2025
8:52 PM
Leap Therapeutics (Issuer)
O'Mahony John Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2025
8:53 PM
LAWLOR AUGUSTINE (Reporting)
Leap Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2025
8:53 PM
Baum Jason (Reporting)
Leap Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2025
8:54 PM
Granfield Christine (Reporting)
Leap Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2025
8:55 PM
Leap Therapeutics (Issuer)
ONSI DOUGLAS E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2025
4:01 PM
Leap Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/26/2025
6:15 AM
Leap Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/26/2025
6:10 AM
Leap Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/17/2025
3:30 PM
Leap Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2025
5:22 AM
BALYASNY ASSET MANAGEMENT L.P. (Filed by)
Leap Therapeutics (Subject)
Form SCHEDULE 13G/A
01/28/2025
7:00 AM
Leap Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/15/2024
4:28 PM
Leap Therapeutics (Issuer)
Mirabelli Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/15/2024
4:29 PM
LAWLOR AUGUSTINE (Reporting)
Leap Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/15/2024
4:30 PM
Leap Therapeutics (Issuer)
ONSI DOUGLAS E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/15/2024
4:31 PM
CAVANAUGH JAMES H (Reporting)
Leap Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2024
5:07 AM
BALYASNY ASSET MANAGEMENT L.P. (Filed by)
Leap Therapeutics (Subject)
Form SC 13G
11/13/2024
6:10 AM
Leap Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2024
5:50 AM
Leap Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/31/2024
5:29 PM
BeiGene, Ltd. (Filed by)
BeiGene, Ltd. (Filed by)
Leap Therapeutics (Subject)
Form SC 13D/A
10/31/2024
4:40 PM
BeiGene, Ltd. (Filed by)
BeiGene, Ltd. (Filed by)
Leap Therapeutics (Subject)
Form SCHEDULE 13D/A
10/04/2024
4:22 PM
Leap Therapeutics (Issuer)
Mashiach Nissim (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2024
4:23 PM
Baum Jason (Reporting)
Leap Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2024
4:23 PM
Leap Therapeutics (Issuer)
Mirabelli Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2024
4:23 PM
CAVANAUGH JAMES H (Reporting)
Leap Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2024
4:24 PM
Dietz Thomas John (Reporting)
Leap Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2024
4:24 PM
LAWLOR AUGUSTINE (Reporting)
Leap Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2024
4:24 PM
Leap Therapeutics (Issuer)
O'Mahony John Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2024
4:24 PM
Leap Therapeutics (Issuer)
LI WILLIAM (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2024
4:25 PM
Leap Therapeutics (Issuer)
LOSCALZO JOSEPH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2024
4:25 PM
Leap Therapeutics (Issuer)
ONSI DOUGLAS E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
The #1 AI Energy Stock (Ad)

Nearly $600 billion is projected to be spent on AI data centers this year. That's because the ones being built now will dwarf everything that came before them. Thanks to AI's ravenous hunger for power … They are beginning to morph into sprawling behemoths.

Click here to learn more about the #1 AI Energy Stock of 2025
10/04/2024
4:25 PM
Leap Therapeutics (Issuer)
Martin Patricia A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2024
4:26 PM
Leap Therapeutics (Issuer)
Richard Christian M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2024
4:27 PM
Leap Therapeutics (Issuer)
Schilsky Richard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2024
4:29 PM
Leap Therapeutics (Issuer)
Sirard Cynthia (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2024
4:29 PM
Granfield Christine (Reporting)
Leap Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2024
6:30 AM
Leap Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/12/2024
6:10 AM
Leap Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/12/2024
5:50 AM
Leap Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/08/2024
3:48 PM
Leap Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:LPTX) was last updated on 7/3/2025 by MarketBeat.com Staff
From Our Partners